BCL2 and melanoma: Additionally, LUT has been reported to promote apoptosis in a variety of tumor cells, including ovarian teratomas (Liu et al., 2019) and melanomas (Yao et al., 2019), by decreasing Bcl-2 expression, increasing Bax expression, and inhibiting the PI3K/Akt signaling pathway.